Robotic Surgery in Gynecology

A study evaluated the effectiveness of robotics in gynecological surgeries––encompassing both benign and malignant cases.

This retrospective observational study was conducted at a single institution – to provide a thorough assessment of potential benefits from the perspective of surgeons. All women who underwent robotic gynecological surgeries between 2015 and 2022 were included in the analysis; robotic surgeries were performed using the Da Vinci Si™ system. Key parameters assessed included operative duration, estimated blood loss, length of hospital stay, complication rates, and conversion rates. Patient age was also analyzed as a demographic factor.

Overall, 211 robotic procedures were performed, comprising – 172 hysterectomies, 20 myomectomies, and 19 surgeries for other gynecological conditions. Mean operating times for hysterectomy and myomectomy were 113 and 129 minutes, respectively, with corresponding drops in hemoglobin levels of 1.34 and 1.2 g/dl. It was noted that none of the surgical groups had a conversion to laparotomy. The benign gynecological cases included procedures such as – ovarian cystectomy, cesarean scar repair, and chronic cornual ectopic surgery.

Robotic surgical systems are proficient in conducting various gynecological procedures, offering advantages comparable to laparoscopic techniques. They are deemed safe and present a promising avenue for comprehensive gynecologic care. Their current applications extend beyond hysterectomy and myomectomy and include procedures like oophorectomy, ovarian cystectomy, endometriosis resection, sacrocolpopexy, and lymphadenectomy. 

The utilization of robotic assistance in laparoscopy is increasingly advocated due to its ability to combat challenges encountered in conventional laparoscopy while ensuring patients benefit from minimally invasive interventions.